Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Predictive value of early molecular response to tyrosine kinase inhibitors in pediatric patient with chronic myeloid leukemia

Predictive value of early molecular response to tyrosine kinase inhibitors in pediatric patient with chronic myeloid leukemia
Abdallah AM et al. Leuk Lymphoma, March 2024 (epub ahead of print)
  
Link to full abstract


 

 

 

 

 

 

Chronic spontaneous urticarial as the presenting factor in a paediatric case of chronic myeloid leukemia (Sutton KM et al. Pediatr Blood Cancer, March 2024)

Chronic spontaneous urticarial as the presenting factor in a paediatric case of chronic myeloid leukemia
Sutton KM et al. Pediatr Blood Cancer, March 2024
  
Link to full abstract


 

 

 

 

 

 

A 3-year old with chronic myeloid leukemia (Coty-Fatall Z & Richardson A. Blood, February 2024)

A 3-year old with chronic myeloid leukemia
Coty-Fatall Z & Richardson A. Blood, February 2024

 
Link to full abstract


 

 

 

 

 

 

Bosutinib in resistant and intolerant pediatric patients with chronic phase CML: Results from the Phase I part study ITCC054/COG AMML1921 (Brivio E et al. J Clin Oncol, March 2024)

Bosutinib in resistant and intolerant pediatric patients with chronic phase chronic myeloid leukemia: Results from the Phase I part of Study ITCC054/COG AMML1921
Brivio E et al. J Clin Oncol, March 2024 – open access publication
 
Link to full abstract


 

 

 

 

 

 

Challenges in management of pediatric chronic myleloid leukemia (pCML) in the low- and middle income countries (LMICs): Insights from an Interntional CML Foundation (iCMLf) Multi National Study (Roy Moulik N et al. Pediatr Hematol Oncol, Jan 2024)

Challenges in management of pediatric chronic myeloid leukemia (pCML) in the low- and middle income countries (LMICs’): Insights from an International CML Foundation (iCMLf) Multi National Study
Roy Moulik N et al. Pediatr Hematol Oncol, January 2024 (epub ahead of print)
 
Link to full abstract


 

 

 

 

  1. Pediatric chronic myeloid leukemia P190 variant with IgA vasculitis: Rare association - case report (Shah K et al. Pediatr Blood Cancer, Jan 2024)
  2. Bosutinib: Pediatric first approval (Hoy SM et al. Paediatr Drugs, Dec 2023)
  3. Skin reactions to tyrosine kinase inhibitors in pediatric patients with chronic myeloid leukemia (Toker M et al. Pediatr Dermatol, Dec 2023)
  4. Treatment and follow-up of children with CML-CP in the TKI era - Two decades of experience from the Tata Memorial Hospital paediatric CML (pCML) cohort (Roy Moulik N et al. Br J Haematol, Dec 2023)